Patients' preferences for ways to communicate benefits of cardiovascular medication

Annals of Family Medicine

Volumn 9, Issue 2, 2011, Pages 121-127

  Goodyear Smith, Felicity ^a   Kenealy, Timothy ^a   Wells, Susan ^a   Arroll, Bruce ^a   Horsburgh, Margaret ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Cardiovascular diseases; Decision making; Family practice; Risk assessment; Risk management

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; DECISION MAKING; DOCTOR PATIENT RELATION; FEMALE; GENERAL PRACTITIONER; HUMAN; INTERPERSONAL COMMUNICATION; MALE; METHODOLOGY; MIDDLE AGED; NEW ZEALAND; PATIENT EDUCATION; PATIENT PREFERENCE; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; RISK; RISK ASSESSMENT; STATISTICAL MODEL;

ADULT; AGED; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; COMMUNICATION; DECISION MAKING; FEMALE; GENERAL PRACTITIONERS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEW ZEALAND; PATIENT EDUCATION AS TOPIC; PATIENT PREFERENCE; PHYSICIAN-PATIENT RELATIONS; QUESTIONNAIRES; RISK; RISK ASSESSMENT;

EID: 79952790304     PISSN: 15441709     EISSN: 15441717     Source Type: Journal    
DOI: 10.1370/afm.1193     Document Type: Article

References (21)

1. New Zealand Guidelines Group. New Zealand Cardiovascular Guidelines Handbook. A Summary Resource for Primary Care Practitioners. Wellington: New Zealand Guidelines Group; 2009.
2. Alaszewski A, Horlick-Jones T. How can doctors communicate information about risk more effectively? BMJ. 2003;327(7417):728-731.
3. Alaszewski A. A person-centred approach to communicating risk. PLoS Med. 2005;2(2):e41.
4. Goodyear-Smith F, Arroll B, Chan L, Jackson R, Wells S, Kenealy T. Patients prefer pictures to numbers to express cardiovascular ben-ef t from treatment. Ann Fam Med. 2008;6(3):213-217.
5. Edwards A, Elwyn G, Covey J, Matthews E, Pill R. Presenting risk information-a review of the effects of "framing" and other manipulations on patient outcomes. J Health Commun. 2001;6(1):61-82.
6. Halvorsen PA, Selmer R, Kristiansen IS. Different ways to describe the benef ts of risk-reducing treatments: a randomized trial. [Summary for patients in Ann Intern Med. 2007 Jun 19;146(12):I50; PMID: 17577002]. Ann Intern Med. 2007;146(12):848-856.
7. Hux JE, Naylor CD. Communicating the benef ts of chronic preventive therapy: does the format of eff cacy data determine patients' acceptance of treatment? Med Decis Making. 1995;15(2):152-157.
8. Bobbio M, Demichelis B, Giustetto G. Completeness of reporting trial results: effect on physicians' willingness to prescribe. Lancet.1994;343(8907):1209-1211.
9. Gigerenzer G, Gaissmaier W, Kurz-Milcke E, Schwartz LM, Woloshin S. Helping doctors and patients make sense of health statistics. Psych Sci Pub Int. 2007;8(2):53-96.
10. Alwan HA, William JB, Viswanathan BB, Paccaud FA, Bovet PAB. Perception of cardiovascular risk and comparison with actual cardiovascular risk. Eur J Cardio Prev Rehab. 2009;16(6):556-561.
11. Friedmann PD, Brett AS, Mayo-Smith MF. Differences in general-ists' and cardiologists' perceptions of cardiovascular risk and the outcomes of preventive therapy in cardiovascular disease. Ann Intern Med. 1996;124(4):414-421.
12. Edwards A, Unigwe S, Elwyn G, Hood K. Effects of communicating individual risks in screening programmes: Cochrane systematic review. [see comment]. BMJ. 2003;327(7417):703-709.
13. Pignone M, Phillips C, Mulrow C. Use of lipid lowering drugs for primary prevention of coronary heart disease: meta-analysis of randomised trials. BMJ. 2000; 321(7267):983-986.
14. Jackson R. Guidelines on preventing cardiovascular disease in clinical practice. BMJ. 2000;320(7236):659-661.
15. Schwartz LM, Woloshin S, Black WC, Welch HG. The role of numeracy in understanding the benef t of screening mammography. Ann Intern Med. 1997;127(11):966-972.
16. Crampton P, Salmond C, Kirkpatrick R. Degrees of Deprivation in New Zealand: An Atlas of Socioeconomic Difference. 2nd ed. Auckland: David Bateman Ltd; 2004.
17. Sheridan SL, Behrend L, Vu MB, Meier A, Griffth JM, Pignone MP. Individuals' responses to global CHD risk: a focus group study. Patient Educ Couns. 2009;76(2):233-239.
18. Edwards A, Unigwe S, Elwyn G, Hood K. Effects of communicating individual risks in screening programmes: Cochrane systematic review. BMJ. 2003;327(7417):703-709.
19. Epstein RM, Alper BS, Quill TE. Communicating evidence for participatory decision making. JAMA. 2004;291(19):2359-2366.
20. Buetow S. Non attendance for health care: when rational beliefs collide. Sociol Rev. 2007;55(3):592-610.
21. Halvorsen PA, Selmer R, Kristiansen IS. Different ways to describe the benef ts of risk-reducing treatments: a randomized trial. Ann Intern Med. 2007;146(12):848-856.